Table of Contents

2019-2024 Global Pain Management Drugs Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Pain Management Drugs Consumption 2014-2024
  • 2.1.2 Pain Management Drugs Consumption CAGR by Region
• 2.2 Pain Management Drugs Segment by Type
  • 2.2.1 Generic Opioids
  • 2.2.2 Branded Opioids
  • 2.2.3 NSAIDs
  • 2.2.4 Others
• 2.3 Pain Management Drugs Consumption by Type
  • 2.3.1 Global Pain Management Drugs Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Pain Management Drugs Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Pain Management Drugs Sale Price by Type (2014-2019)
• 2.4 Pain Management Drugs Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Clinics
  • 2.4.3 Drugstores
• 2.5 Pain Management Drugs Consumption by Application
  • 2.5.1 Global Pain Management Drugs Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Pain Management Drugs Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Pain Management Drugs Sale Price by Application (2014-2019)

3 Global Pain Management Drugs by Players

• 3.1 Global Pain Management Drugs Sales Market Share by Players
  • 3.1.1 Global Pain Management Drugs Sales by Players (2017-2019)
  • 3.1.2 Global Pain Management Drugs Sales Market Share by Players (2017-2019)
• 3.2 Global Pain Management Drugs Revenue Market Share by Players
  • 3.2.1 Global Pain Management Drugs Revenue by Players (2017-2019)
  • 3.2.2 Global Pain Management Drugs Revenue Market Share by Players (2017-2019)
• 3.3 Global Pain Management Drugs Sale Price by Players
• 3.4 Global Pain Management Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Pain Management Drugs Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Pain Management Drugs Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Pain Management Drugs by Regions

• 4.1 Pain Management Drugs by Regions
  • 4.1.1 Global Pain Management Drugs Consumption by Regions
  • 4.1.2 Global Pain Management Drugs Value by Regions
• 4.2 Americas Pain Management Drugs Consumption Growth
• 4.3 APAC Pain Management Drugs Consumption Growth
• 4.4 Europe Pain Management Drugs Consumption Growth
• 4.5 Middle East & Africa Pain Management Drugs Consumption Growth

5 Americas

• 5.1 Americas Pain Management Drugs Consumption by Countries
  • 5.1.1 Americas Pain Management Drugs Consumption by Countries (2014-2019)
  • 5.1.2 Americas Pain Management Drugs Value by Countries (2014-2019)
• 5.2 Americas Pain Management Drugs Consumption by Type
• 5.3 Americas Pain Management Drugs Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Pain Management Drugs Consumption by Countries
  • 6.1.1 APAC Pain Management Drugs Consumption by Countries (2014-2019)
  • 6.1.2 APAC Pain Management Drugs Value by Countries (2014-2019)
• 6.2 APAC Pain Management Drugs Consumption by Type
• 6.3 APAC Pain Management Drugs Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Pain Management Drugs by Countries
  • 7.1.1 Europe Pain Management Drugs Consumption by Countries (2014-2019)
  • 7.1.2 Europe Pain Management Drugs Value by Countries (2014-2019)
• 7.2 Europe Pain Management Drugs Consumption by Type
• 7.3 Europe Pain Management Drugs Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Pain Management Drugs by Countries
  • 8.1.1 Middle East & Africa Pain Management Drugs Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Pain Management Drugs Value by Countries (2014-2019)
• 8.2 Middle East & Africa Pain Management Drugs Consumption by Type
• 8.3 Middle East & Africa Pain Management Drugs Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Pain Management Drugs Distributors
• 10.3 Pain Management Drugs Customer

11 Global Pain Management Drugs Market Forecast

• 11.1 Global Pain Management Drugs Consumption Forecast (2019-2024)
• 11.2 Global Pain Management Drugs Forecast by Regions
  • 11.2.1 Global Pain Management Drugs Forecast by Regions (2019-2024)
  • 11.2.2 Global Pain Management Drugs Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Pain Management Drugs Forecast by Type
• 11.8 Global Pain Management Drugs Forecast by Application

12 Key Players Analysis

• 12.1 Pfizer
  • 12.1.1 Company Details
  • 12.1.2 Pain Management Drugs Product Offered
  • 12.1.3 Pfizer Pain Management Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Pfizer News
• 12.2 GSK
  • 12.2.1 Company Details
  • 12.2.2 Pain Management Drugs Product Offered
  • 12.2.3 GSK Pain Management Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 GSK News
• 12.3 Grunenthal
  • 12.3.1 Company Details
  • 12.3.2 Pain Management Drugs Product Offered
  • 12.3.3 Grunenthal Pain Management Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Grunenthal News
• 12.4 Bayer
  • 12.4.1 Company Details
  • 12.4.2 Pain Management Drugs Product Offered
  • 12.4.3 Bayer Pain Management Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Bayer News
• 12.5 Sanofi
  • 12.5.1 Company Details
  • 12.5.2 Pain Management Drugs Product Offered
  • 12.5.3 Sanofi Pain Management Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Sanofi News
• 12.6 Eli Lilly
  • 12.6.1 Company Details
  • 12.6.2 Pain Management Drugs Product Offered
  • 12.6.3 Eli Lilly Pain Management Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Eli Lilly News
• 12.7 AstraZeneca
  • 12.7.1 Company Details
  • 12.7.2 Pain Management Drugs Product Offered
  • 12.7.3 AstraZeneca Pain Management Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 AstraZeneca News
• 12.8 Endo
  • 12.8.1 Company Details
  • 12.8.2 Pain Management Drugs Product Offered
  • 12.8.3 Endo Pain Management Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Endo News
• 12.9 Merck
  • 12.9.1 Company Details
  • 12.9.2 Pain Management Drugs Product Offered
  • 12.9.3 Merck Pain Management Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Merck News
• 12.10 Depomed
  • 12.10.1 Company Details
  • 12.10.2 Pain Management Drugs Product Offered
  • 12.10.3 Depomed Pain Management Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Depomed News
• 12.11 Yunnan Baiyao
• 12.12 Teva
• 12.13 J&J
• 12.14 Allergan
• 12.15 Purdue

13 Research Findings and Conclusion

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
The classification of pain management drugs includes opioids, NSAIDs and other types, and the proportion of opioids is about 47% in 2016, and the proportion is in decreasing trend from 2012 to 2017.
North America is the largest consumption place, with a consumption market share nearly 37% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
Market competition is intense. Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

According to this study, over the next five years the Pain Management Drugs market will register a 2.8% CAGR in terms of revenue, the global market size will reach US$ 41900 million by 2024, from US$ 35600 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pain Management Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Pain Management Drugs market by product type, application, key manufacturers and key regions and countries.

This study considers the Pain Management Drugs value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Generic Opioids
Branded Opioids
NSAIDs
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Drugstores

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Pain Management Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pain Management Drugs market by identifying its various subsegments.
Focuses on the key global Pain Management Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pain Management Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pain Management Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.